New drug tested to shrink tumors before colon cancer surgery
NCT ID NCT07405476
Summary
This study is testing if a drug called zanidatamab can shrink tumors before surgery in people with early-stage colon or rectal cancer that has a specific marker called HER2. The goal is to see if this pre-surgery treatment helps improve outcomes. About 38 participants will receive the drug by IV infusion for several cycles before their standard cancer surgery and follow-up care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Emory University Hospital
Atlanta, Georgia, 30322, United States
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.